Differential regulation of cathepsin S and cathepsin L in interferon γ-treated macrophages

被引:87
作者
Beers, C
Honey, K
Fink, S
Forbush, K
Rudensky, A
机构
[1] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA
[3] Univ Washington, Med Sci Training Program, Seattle, WA 98195 USA
关键词
cathepsin; macrophage; Ii processing; IFN-gamma; p4l;
D O I
10.1084/jem.20020978
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cathepsin S (catS) and cathepsin L (catL) mediate late stages of invariant chain (Ii) degradation in discrete antigen-presenting cell types. Macrophages (Mphis) are unique in that they express both proteases and here we sought to determine the relative contribution of each enzyme. We observe that catL plays no significant role in Ii cleavage in interferon (IFN)-gamma-stimulated Mphis. In addition, our studies show that the level of catL activity is significantly decreased in Mphis cultured in the presence of IFN-gamma whereas catS activity increases. The decrease in catL activity upon cytokine treatment occurs despite the persistence of high levels of mature catL protein, suggesting that a specific inhibitor of the enzyme is up-regulated in IFN-gamma-stimulated peritoneal Mphis. Similar inhibition of activity is observed in dendritic cells engineered to overexpress catL. Such enzymatic inhibition in Mphis exhibits only partial dependence upon Ii and therefore, other mechanisms of catL inhibition are regulated by IFN-gamma. Thus, during a T helper cell type 1 immune response catL inhibition in Mphis results in preferential usage of catS, such that major histocompatibility complex class II presentation by all bone marrow-derived antigen-presenting cell is regulated by catS.
引用
收藏
页码:169 / 179
页数:11
相关论文
共 45 条
[31]   The optimum dietary protein level for the Mexican cichlid Cichlasoma urophthalmus (Gunther): a comparison of estimates derived from experiments using fixed-rate feeding and satiation feeding [J].
Martinez-Palacios, C. A. ;
Harfush-Melendez, M. ;
Chavez-Sanchez, C. ;
Ross, L. G. .
AQUACULTURE NUTRITION, 1996, 2 (01) :11-20
[32]   THE IDENTIFICATION OF ACTIVE FORMS OF CYSTEINE PROTEINASES IN KIRSTEN-VIRUS-TRANSFORMED MOUSE FIBROBLASTS BY USE OF A SPECIFIC RADIOLABELED INHIBITOR [J].
MASON, RW ;
WILCOX, D ;
WIKSTROM, P ;
SHAW, EN .
BIOCHEMICAL JOURNAL, 1989, 257 (01) :125-129
[33]   Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus [J].
Nakagawa, T ;
Roth, W ;
Wong, P ;
Nelson, A ;
Farr, A ;
Deussing, J ;
Villadangos, JA ;
Ploegh, H ;
Peters, C ;
Rudensky, AY .
SCIENCE, 1998, 280 (5362) :450-453
[34]   Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice [J].
Nakagawa, TY ;
Brissette, WH ;
Lira, PD ;
Griffiths, RJ ;
Petrushova, N ;
Stock, J ;
McNeish, JD ;
Eastman, SE ;
Howard, ED ;
Clarke, SRM ;
Rosloniec, EF ;
Elliott, EA ;
Rudensky, AY .
IMMUNITY, 1999, 10 (02) :207-217
[35]   The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation [J].
Nakagawa, TY ;
Rudensky, AY .
IMMUNOLOGICAL REVIEWS, 1999, 172 :121-129
[36]   INTRACELLULAR-TRANSPORT OF MHC CLASS-II MOLECULES [J].
NEEFJES, JJ ;
PLOEGH, HL .
IMMUNOLOGY TODAY, 1992, 13 (05) :179-184
[37]   Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor [J].
Ni, J ;
Fernandez, MA ;
Danielsson, L ;
Chillakuru, RA ;
Zhang, JL ;
Grubb, A ;
Su, J ;
Gentz, R ;
Abrahamson, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24797-24804
[38]   Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells [J].
Pierre, P ;
Mellman, I .
CELL, 1998, 93 (07) :1135-1145
[39]   Essential role for cathepsin S in MHC class II - Associated invariant chain processing and peptide loading [J].
Riese, RJ ;
Wolf, PR ;
Bromme, D ;
Natkin, LR ;
Villadangos, JA ;
Ploegh, HL ;
Chapman, HA .
IMMUNITY, 1996, 4 (04) :357-366
[40]   Cathepsin S activity regulates antigen presentation and immunity [J].
Riese, RJ ;
Mitchell, RN ;
Villadangos, JA ;
Shi, GP ;
Palmer, JT ;
Karp, ER ;
De Sanctis, GT ;
Ploegh, HL ;
Chapman, HA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2351-2363